OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,149 | – | 3,254 | +2462.2% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 127 | -99.2% | 0.00% | -100.0% |
| Q4 2021 | $105,000 | +138.6% | 15,108 | +379.5% | 0.01% | +200.0% |
| Q2 2021 | $44,000 | +131.6% | 3,151 | +162.6% | 0.00% | +50.0% |
| Q1 2021 | $19,000 | -62.0% | 1,200 | -51.1% | 0.00% | -60.0% |
| Q4 2020 | $50,000 | +56.2% | 2,454 | -42.7% | 0.01% | +25.0% |
| Q3 2020 | $32,000 | -23.8% | 4,282 | -16.9% | 0.00% | -33.3% |
| Q2 2020 | $42,000 | +740.0% | 5,152 | +288.0% | 0.01% | – |
| Q4 2017 | $5,000 | -54.5% | 1,328 | -31.1% | 0.00% | -100.0% |
| Q3 2017 | $11,000 | -26.7% | 1,928 | +13.6% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | -40.0% | 1,697 | -38.8% | 0.00% | -66.7% |
| Q1 2017 | $25,000 | +4.2% | 2,772 | -6.4% | 0.00% | 0.0% |
| Q4 2016 | $24,000 | – | 2,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |